Appl Clin Inform 2025; 16(04): 1053-1059
DOI: 10.1055/a-2666-4737
Special Issue on CDS Failures

Clinical Decision Support Aiming to Accelerate Triage and Time to Dextrose-Containing IV Fluids in the ED for Children with Severe Metabolic Conditions

Swaminathan Kandaswamy
1   Department of Pediatrics, Emory University, Atlanta, Georgia, United States
,
Shabnam Jain
1   Department of Pediatrics, Emory University, Atlanta, Georgia, United States
2   Division of Emergency Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
,
Dwight Diaz Chambers
3   Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, United States
,
William R. Wilcox
2   Division of Emergency Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
4   Department of Human Genetics and Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States
,
Beesan S. Agha
5   Division of Emergency Medicine Children's Healthcare of Atlanta, Atlanta, Georgia, United States
6   Pediatric Emergency Medicine Associates, Atlanta, Georgia, United States
,
Hailey Dennis
4   Department of Human Genetics and Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States
,
Sara P. Brown
7   Division of Information Systems and Technology, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
,
Evan W. Orenstein
1   Department of Pediatrics, Emory University, Atlanta, Georgia, United States
8   Division of Information Systems and Technology, Children's Healthcare of Atlanta, Atlanta, Georgia, United States
› Author Affiliations
Preview

Abstract

Objectives

This study aimed to describe human-centered design of clinical decision support (CDS) for children with metabolic diseases at high risk of rapid decompensation, assess the influence of CDS on care processes and patient outcomes, and share insights from the implementation.

Methods

A CDS was designed in collaboration with pediatric genetics experts to provide accelerated triage and recommend dextrose-containing fluids for patients metabolic conditions. Formative usability testing was conducted with emergency department (ED) nurses and providers. Pre- and post-intervention data on triage, alert acceptance, and order set usage, as well as clinical outcomes such as time to dextrose fluids, intensive care unit (ICU) admission rates, and length of stay, were compared.

Results

Provider alert acceptance was at 39%. Following CDS implementation, nurse triage at Emergency Severity Index (ESI) <3 (ESI 1 or ESI 2 to escalate patients with metabolic conditions to a higher severity) increased from 84 to 98%. Time to dextrose-containing fluids from patient rooming to administration decreased significantly from 101 to 82 minutes (p = 0.006) for all patients with metabolic conditions, and from 110 to 88 minutes (p = 0.029) for those admitted to the hospital. However, the median time from arrival to fluids administration saw a non-significant reduction from 114 to 102 minutes (p = 0.07). ICU admission rates remained stable pre- and post-intervention (13% vs. 14%; p = 0.60), and there was no significant change in total length of stay.

Conclusion

The CDS, developed through a user-centered design approach, improved appropriateness of triage acuity rates and reduced the time from rooming to administration of dextrose-containing fluids for children with metabolic diseases at risk of rapid decompensation. The study did not demonstrate a significant change in ICU admissions or length of stay, possibly due to increased patient load and external factors. The findings emphasize the importance of usability testing and clinician-centered design for effective CDS integration.

Protection of Human and Animal Subjects

This work was done as part of quality improvement in operations and was deemed non-human subjects research (STUDY00000393).


Supplementary Material



Publication History

Received: 23 January 2025

Accepted: 25 July 2025

Article published online:
11 September 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany